The uPA/uPAR activity by the tumor cells arriving at the bone not only degrades the bone ECM, such as collagen I, fibronectin, and laminin through plasmin-mediated proteolysis, but also simultaneously promotes osteoclast differentiation and activity [168,182]. The gene discussed is PLAU; the disease is neoplasm.